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Introduction
Recently, a novel human hereditary anomaly syndrome was recognized in association with loss-of-function 
mutations in the TASP1 gene (1–3). Those patients were characterized with microcephaly, developmental 
delay, distinctive facial features, and other anomalies, including anemia, thrombocytopenia, and lympho-
cytopenia (2, 3). TASP1 codes for Taspase1, which is an evolutionarily conserved threonine protease that 
cleaves and regulates nuclear proteins, most notably, MLL (KMT2A, also known as MLL1) and TFIIAα-β 
(4–6). Taspase1 is a 50 kD α-β proenzyme that undergoes intramolecular autoproteolysis to produce mature, 
active α28/β22 heterodimeric protease (4, 6–8). Cleavage of  Taspase1 substrates occurs distal to the aspar-
tate residue within the conserved IXQL(V)D/G motif  (4, 9).
The bona fide Taspase1 substrates are MLL1, MLL2 (also known as KMT2B), TFIIAα-β (also known 
as GTF2A1), ALF (TFIIA-like factor, also known as GTF2A1L) and Drosophila HCF (dHCF) (4, 5, 10–
12). MLL1, a member of  the trithorax group (Trx-G) epigenetic modifiers, is a histone methyl transferase 
(HMT) that trimethylates H3 at lysine 4, generating a histone mark of  active transcription (13, 14). In 
the absence of  proteolytic activation, immature MLL1 polypeptide displays reduced HMT activity and, 
hence, functions as a hypomorphic mutant (11). TFIIA, comprising 3 polypeptides (α, β, and γ), complexes 
with TATA-binding protein (TBP) and constitutes an integral part of  the basal transcription machinery 
(15–19). Precursor TFIIAα-β, encoded by a single gene, Gtf2a1, is processed into TFIIAα and -β subunits 
by Taspase1-mediated cleavage (5). Complexes of  TFIIAα-β/γ containing noncleaved TFIIAα-β have tran-
scriptional activity in vitro, and its maturation into TFIIAα/β/γ increases its susceptibility to regulatory 
degradation (5). In addition, TFIIAα-β/γ and TFIIAα/β/γ are different in the pattern of  interactions with 
TFIID, an important factor for promoter recognition (20). Since TBP-like protein was reported to be a neg-
ative regulator of  the Taspase1-mediated processing of  TFIIA, Taspase1 may fine-tune the transcription of  
Taspase1, a highly conserved threonine protease encoded by TASP1, cleaves nuclear histone-
modifying factors and basal transcription regulators to orchestrate diverse transcription programs. 
Hereditary loss-of-function mutation of TASP1 has recently been reported in humans as resulting 
in an anomaly complex syndrome, which manifests with hematological, facial, and skeletal 
abnormalities. Here, we demonstrate that Taspase1-mediated cleavage of TFIIAα-β, rather than 
of MLL1 or MLL2, in mouse embryos was required for proper fetal liver hematopoiesis and correct 
segmental identities of the axial skeleton. Homozygous genetic deletion of Taspase1 disrupted 
embryonic hematopoietic stem cell self-renewal and quiescence states and axial skeleton fates. 
Strikingly, mice carrying knockin noncleavable mutations of TFIIAα-β, a well-characterized basal 
transcription factor, displayed more pronounced fetal liver and axial skeleton defects than those 
with noncleavable MLL1 and MLL2, 2 trithorax group histone H3 trimethyl transferases. Our study 
offers molecular insights into a syndrome in humans that results from loss of TASP1 and describes 
an unexpected role of TFIIAα-β cleavage in embryonic cell fate decisions.
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genes through these factors (21). Previous studies revealed that the proteolytic cleavage of  TFIIA is critical 
for male spermiogenesis (22) and craniofacial development (23).
Taspase1-mediated cleavage of  each substrate may account for various phenotypes of  Taspase1 defi-
ciency, or, alternatively, protease-independent biological activities of  Taspase1 may exist. Here, we per-
formed mouse genetic studies to interrogate the biological significance of  cleavage of  MLL1, MLL2, and 
TFIIA. Taspase1-mediated cleavage of  TFIIA has the most prominent effects on fetal hematopoiesis as 
well as on the specification of  axial skeleton, offering molecular insights concerning a syndrome in humans 
that results from loss of  TASP1.
Results
To investigate the physiological function of  Taspase1, we generated Tasp1-deficient mice (Tasp1–/– mice). 
Our initial report demonstrated that these animals displayed marked homeotic transformation of  the axial 
skeleton and a decrease in overall body size (11). Furthermore, Tasp1–/– mice die shortly after birth, partly 
due to feeding defects (11). Here, we further examined the role of  Taspase1 in embryogenesis and initiated 
studies by comparing these Tasp1–/– and WT littermate embryos. Tasp1–/– E14.5 embryos show a severe 
developmental retardation, reflected by an approximately 40% reduction in overall weight in comparison to 
that of  WT embryos (Figure 1A). Furthermore, Tasp1–/– embryos have markedly smaller fetal livers (Figure 
1B). The decrease in fetal liver cell number was significant even after normalizing for reduced body weight 
(P < 0.001) (Figure 1A).
We next analyzed the fetal liver for mature blood cell lineages and the hematopoietic stem and progenitor 
cell compartments using multicolor flow cytometry. The analysis of  E14.5 fetal livers showed that Tasp1–/– 
and WT fetal livers had little difference in the populations of  B220+ B cells, Gr-1+ granulocytes, and TER-119+ 
red blood cells (Figure 1C). In contrast, the stem and progenitor cell populations, marked by Lin–Sca-1+c-
Kit+ staining (so-called LSK cells), were reduced in Tasp1–/– fetal livers (Figure 1, D and E). LSK cells can 
be further specified as multipotent progenitor cells (MPPs; Lin–Sca-1+c-Kit+CD150–) or hematopoietic stem 
cells (HSCs; Lin–Sca-1+c-Kit+CD150+) (24, 25). In Tasp1–/– fetal livers, the abundance of  HSCs was found to 
be reduced to approximately half  that of  the WT fetal liver (Figure 1E), resulting in an approximately 78% 
decrease in the absolute number of  HSCs (Figure 1F). No difference in the frequency of  Lin–Sca-1–c-Kit+ 
myeloid progenitors was observed, whereas absolute numbers of  these cells were decreased. Specifically, in 
Tasp1–/– fetal livers, the relative abundance of  common myeloid progenitors (CMPs), granulocyte-monocyte 
progenitors (GMPs), and megakaryocyte-erythrocyte progenitors (MEPs) was normal (Figure 1, D and E). 
Together, our data indicate that, in the mouse fetal liver, Taspase1 may be required for the development and 
maintenance of  the HSC compartment.
Accordingly, we investigated how Taspase1 loss leads to impaired fetal liver HSC renewal. Loss of  
Taspase1 activity could lead to increased cell death and/or aberrant cell cycle control. Cell death analysis 
of  LSK cells and HSCs showed no increase of  apoptosis in Tasp1–/– fetal livers (Figure 2A). On the other 
hand, cell cycle analysis of  MPPs and HSCs yielded a marked difference between WT and Tasp1–/– cells. 
Most notably staining of  DNA and RNA with 7-AAD and pyronin Y, respectively, showed that more 
Tasp1–/– fetal liver HSCs exited stem cell quiescence, with decreased number of  cells in the G0 phase, where-
as the majority of  WT HSCs were in the G0 phase, with fewer cells at G1 and S/G2/M (Figure 2, B and C). 
In contrast, Tasp1–/– fetal liver MPPs displayed similar cell cycle profile as WT MPPs. Strikingly, the cell 
cycle profile observed of  Tasp1–/– fetal liver HSCs resembles that of  MPPs (Figure 2B).
To elucidate by which substrate(s) cleavage of  Taspase1 regulates fetal liver hematopoiesis, we 
first focused on the MLL family proteins MLL1 and MLL2. MLL1 is the best-characterized Taspase1 
substrate, controls Hox and Cylclin gene expression, and plays a critical role in both fetal and adult 
hematopoiesis (26–28). Homozygous knockin of  noncleavable (nc) Mll1 mutant alleles (Mll1nc/nc) at the 
endogenous Mll1 locus did not reduce the overall fetal liver cellularity (Figure 3A) but incurred a minor 
decrease in frequency and number of  HSCs (Figure 3B). As published data suggest a partial redundancy 
between Mll1 and Mll2 (11), we analyzed E14.5 fetal livers of  Mll1nc/nc;2nc/nc embryos bearing homo-
zygous knockin of  nc Mll1 and nc Mll2 mutant alleles at their native genomic loci and did not detect 
reduced fetal liver cellularity or body weight (Figure 3C). Similarly, the reduced abundance or absolute 
number of  HSCs in Mll1nc/nc;2nc/nc fetal livers was not statistically significant (Figure 3D).
TFIIA family proteins TFIIAα-β and ALF are the only bona fide mammalian Taspase1 substrates 
known thus far besides MLL1 and MLL2. As expression of  ALF is restricted to the mammalian testis (29), 
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we focused on the noncleavage of  TFIIAα-β. We have created a Gtf2a1nc/nc mouse model in which the endog-
enous D/G cleavage residues of  TFIIAα-β are replaced with noncleavable A/A and have reported that 
Gtf2a1nc/nc males are infertile (22). Remarkably, Gtf2a1nc/nc embryos were smaller than their WT littermates, 
and their livers were disproportionally smaller (Figure 4, A and B). Furthermore, the frequencies of  HSCs 
in Gtf2a1nc/nc fetal livers were also reduced (Figure 4D). In fact, the absolute HSC number of  Gtf2a1nc/nc fetal 
livers was approximately 30% of  that of  their WT littermates (Figure 4E). Similar to Tasp1–/– embryos, there 
were no significant changes in the frequency of  myeloid progenitors, CMPs, GMPs, or MEPs in Gtf2a1nc/nc 
fetal livers (Figure 4, C and D). Cell cycle analysis of  Gtf2a1nc/nc fetal liver stem and progenitor cells demon-
strated decreased a number of  Gtf2a1nc/nc HSCs in the G0 phase, which is reminiscent to that of  WT and 
Gtf2a1nc/nc MPPs (Figure 5). The decrease in G0 phase and the coinciding increases in non-G0 phases of  the 
Figure 1. Taspase1 deficiency results in fetal liver hematopoietic stem cell defects. (A) Body weight and cell numbers 
of fetal livers (FLs) normalized to body weight of E14.5 embryos of the indicated WT and Taspase1-knockout (Tasp1–/–) 
embryos. Boxes contain the 25th to 75th percentiles of data sets, with 50th percentile center lines, and whiskers mark the 
5th and 95th percentiles. Outliers are shown by dots. (B) Images of E14.5 FLs of the indicated genotypes. Scale bar: 2 mm. 
(C) Frequency of E14.5 FL cells committed to erythroid (TER-119+), myeloid (Gr-1+), and B cell (B220+) lineages. (D) Progen-
itor and stem cell analyses of E14.5 FL cells by flow cytometry. Lin–Sca-1+c-Kit+ cells are defined as LSK, and Lin–Sca-1–c-
Kit+ cells as myeloid progenitors. Myeloid progenitors are subdivided into CMP, GMP, and MEP by CD34 and CD16/32. LSK 
CD150+ cells are defined as HSCs. (E) Quantification of stem and progenitor cells of 15 WT and 12 Tasp1–/– FLs. (F) HSCs per 
E14.5 FL of the indicated genotypes. Numbers were calculated by multiplying FL cellularity and HSC frequency. Data are 
shown as the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by Mann-Whitney U test. HSC, hematopoietic stem cell; 
CMP, common myeloid progenitor; GMP, granulocyte-monocyte progenitor; MEP, megakaryocyte-erythrocyte progenitor.
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Gtf2a1nc/nc fetal liver HSCs indicated a stem cell quiescence defect similar to that observed in Tasp1–/– fetal liv-
er HSCs (Figure 2, B and C). These striking similarities between Gtf2a1nc/nc and Tasp1–/– fetal livers highlight 
the importance of  the Taspase1-TFIIA axis in the maintenance of  fetal liver HSCs.
To further investigate this potentially novel regulation, we employed stem cell transplant assays to eval-
uate the capacity of  Tasp1–/– and Gtf2a1nc/nc fetal liver HSCs in long-term hematopoietic reconstitution. Com-
petitive repopulation assays were performed by transplanting 150 CD45.2+ HSCs from WT, Tasp1–/–, or 
Gtf2a1nc/nc E14.5 fetal livers along with CD45.1+ competitor cells into lethally irradiated CD45.1+ mice (Fig-
ure 6A). Twelve weeks after transplantation, peripheral blood was analyzed for the contribution of  donor-de-
rived HSCs to mature blood lineages, including B220+ for B cells, CD3+ for T cells, and Gr-1+Mac-1+ for 
myeloid cells (Figure 6, B and C). More than 5% of  CD45.2+ donor-derived cells in all 3 lineages were 
detected in 13 of  19 mice transplanted with WT HSCs, whereas multilineage reconstitution was detected in 
neither the 9 mice transplanted with Tasp1–/– HSCs nor the 8 mice transplanted with Gtf2a1nc/nc HSCs (Table 
1). Thus, the Taspase1-TFIIA axis appears to be required for long-term reconstitution of  hematopoietic cells 
from fetal livers, suggesting its role in long-term HSC self-renewal.
The phenotypic similarities between Gtf2a1nc/nc and Tasp1–/– fetal liver HSCs indicate that TFI-
IA is the principal Taspase1 substrate conferring Taspase1-orchestrated fetal liver hematopoiesis. 
As noncleaved TFIIAα-βnc is more stable than cleaved TFIIA (5, 22) and no apparent abnormalities 
were detected in Gtf2a1nc/+ fetal livers (data not shown), TFIIAα-βnc is unlikely to function as a domi-
nant-negative mutant in fetal liver hematopoiesis. Instead, data favors cleaved TFIIA positively regu-
lating fetal liver hematopoiesis.
Hox genes of  the vertebrates and homeotic genes of  the invertebrates play critical roles in imple-
menting body plan, and their deregulation results in the loss of  segmental identities, i.e., homeotic trans-
formation. As our previous studies demonstrated that Tasp1–/– mice exhibit homeotic transformation 
(11), we examined the axial skeleton of  Gtf2a1nc/nc newborn pups (n = 17) and detected overt homeotic 
Figure 2. Tasp1–/– fetal liver hematopoietic stem cells exhibit an aberrant cell cycle profile reminiscent of multipotent progenitor cells. (A) Cell 
death analysis quantified by annexin V staining. The frequency of annexin V+ cells in fetal liver (FL) hematopoietic stem cell (HSC) and LSK cells of 
the indicated genotypes was displayed (WT, n = 3; Tasp1–/–, n = 5). Data are shown as the mean ± SEM. (B and C) Cell cycle analysis of FL HSCs and 
multipotent progenitor cells (MPPs). Cells were stained with 7-AAD and pyronin Y to assess DNA and RNA contents, respectively. (B) The quadrant 
gates of the representative plots based on DNA and RNA contents are outlined as G0, G1 and S/G2/M phases. (C) The frequency of HSCs and MPPs 
in G0 and non-G0 (G1 and S/G2/M) phases. Data are shown as the mean ± SEM (n = 4 for all samples). P values of 4 independent experiments by χ
2 
testing were combined by the Fisher’s method; ***P < 0.001.
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transformations, including abnormal anterior arch of  atlas (a.a.a.) (82%), split of  C2 (cervical vertebra) 
(18%), fusion of  C3 to C5 (29%), posterior transformation of  C7 (65%), anterior transformation of  T8 
(thoracic) (12%), incomplete ossification of  sternebra 4 (65%), incomplete segmentation of  sternebrae 3 
and 4 (24%), and posterior transformation of  L6 (lumbar) (53%) (Figure 7 and Table 2). Unexpectedly, 
homeotic defects of  Gtf2a1nc/nc newborns were more profound than those of  Mll1nc/nc;2nc/nc newborns and 
highly reminiscent of  those of  Tasp1–/– newborns (Figure 7 and Table 2). Homeotic transformation of  the 
axial skeletons is the defining feature of  Hox gene deregulation (30, 31), and these extensive homeotic 
defects in Gtf2a1nc/nc mice indicate a potentially novel regulation of  Hox genes by TFIIA, a basal transcrip-
tion factor, through a site-specific proteolytic process.
Discussion
Unlike most reversible posttranslational protein modifications, such as phosphorylation, acetylation, and 
methylation, proteolysis through either degradation or site-specific cleavage renders structural chang-
es permanent and, thereby, potentially results in long-lasting functional consequences. In metazoans, 
site-specific proteolysis regulates critical aspects of  biology, such as the activation of  blood coagulation 
factors for hemostasis, the activation of  caspases for cell death execution, the cleavage of  Notch intracel-
lular domain for cell fate determination, the release of  SREBP for cholesterol homeostasis (32), the mat-
uration of  HCF and MLL1 for cell cycle progression (11, 12), and the assembly of  mature TFIIAα/β/γ 
for male germ cell maturation (5, 22). Indeed, the identification and functional characterization of  pro-
teases and their cognate substrates have been instrumental in unraveling the underlying mechanisms 
concerning diverse biological processes.
Taspase1 is a highly conserved protease that orchestrates a plethora of  genetic programs through 
cleaving nuclear transcription regulators, MLL1, MLL2, TFIIA, ALF, and dHCF (6, 33). Given that 
TFIIA is a basal transcription factor and Hox genes are highly specialized transcription factors, the 
Figure 3. Hematopoietic stem cell quantification of Mll1nc/nc and Mll1nc/nc;2nc/nc fetal livers. (A and B) Embryos obtained 
by intercrossing Mll1nc/+ mice were analyzed. (A) Body weight and normalized E14.5 fetal liver (FL) cellularity. (B) Fre-
quency of hematopoietic stem cells (HSCs) and number of HSCs per FL (WT, n = 8; Mll1nc/nc, n = 8). (C and D) Embryos 
obtained by intercrossing Mll1nc/nc;2nc/+ mice were analyzed. (C) Body weight and normalized E14.5 FL cellularity. (D) 
Frequency of HSCs and number of HSCs per FL (Mll1nc/nc;2+/+, n = 6; Mll1nc/nc;2nc/nc, n = 10). Data are shown as the mean ± 
SEM. P values were determined by Mann-Whitney U test.
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connections between Taspase1-mediated proteolytic processing of  TFIIA and transcriptional regu-
lation of  Hox genes were completely unexpected, adding an additional layer of  complexity to the 
intricate control of  Hox gene expression through upstream transcription factors, epigenetic regulators, 
and long intergenic noncoding RNA (34, 35) for constructing segmental body plan and specifying cell 
lineages including stem cells.
Figure 4. Gtf2a1nc/nc hema-
topoietic stem cells exhibit 
overt fetal liver hematopoiesis 
defects. (A) Body weight and 
normalized fetal liver (FL) cellu-
larity of 19 WT and 27 Gtf2a1nc/nc  
E14.5 FLs. Boxes contain the 
25th to 75th percentiles of data 
sets, with 50th percentile center 
lines, and whiskers mark the 5th 
and 95th percentiles. Outliers 
are shown by dots. ***P < 0.001 
by Mann-Whitney U test. (B) 
Images of E14.5 FLs of the indi-
cated WT and Gtf2a1nc/nc  
embryos. Scale bar: 2 mm. 
(C and D) Quantification of 
hematopoietic stem and pro-
genitor cells of E14.5 FLs by flow 
cytometry. (C) Representative 
dot plots. (D) The frequency of 
stem and progenitor cells in FLs. 
(E) The number of hematopoi-
etic stem cells (HSCs) per FL. 
Data are shown as the mean ± 
SEM. **P < 0.01, ***P < 0.001 by 
Mann-Whitney U test (WT, n = 
6; Gtf2a1nc/nc, n = 8).
Figure 5. Aberrant cell cycle 
profile of Gtf2a1nc/nc hemato-
poietic stem cells. Cell cycle 
analysis of Gtf2a1nc/nc E14.5 fetal 
liver (FL) hematopoietic stem 
cells (HSC) and multipotent 
progenitor cells (MPPs). (A) The 
quadrant gates defining G0, G1, 
and S/G2/M phases. (B) The 
frequency of HSCs and MPPs in 
G0 and non-G0 (G1 and S/G2/M) 
phases. Data are shown as the 
mean ± SEM (n = 4 for all sam-
ples). P values of 4 independent 
experiments by χ2 testing were 
combined by the Fisher’s meth-
od; **P < 0.01.
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The paradigm of  Taspase1 function provides an opportunity to investigate how proteases inter-
connect diverse genetic programs via site-specific proteolysis. In the absence of  Taspase1-mediat-
ed cleavage, MLL1, MLL2, and TFIIAα-β retain partial activity and animals bearing noncleaved 
MLL1, MLL2, and/or TFIIAα-β manifest hypomorphism in several biological settings (11, 22, 36, 
37). Consequently, the alleles encoding nc MLL1, MLL2, and TFIIAα-β differ from null alleles and 
thus provide invaluable insight in cases where genetic ablation results in early embryonic lethality. 
Likewise, Taspase1 deficiency appears to offer a unique opportunity to uncover signaling pathways 
Figure 6. Tasp1–/– and 
Gtf2a1nc/nc fetal liver 
hematopoietic stem 
cells fail to reconstitute 
lethally irradiated recipient 
mice. (A) Outline of the 
experimental design of 
long-term competitive 
repopulation assays. (B) 
Scatterplots showing the 
frequency of donor-derived 
B cell (B220+), T cell (CD3+) 
and myeloid (Gr-1+Mac-1+) 
lineages reconstituted at 
12 weeks after transplant. 
Data are shown as the 
average ± SEM. WT, n = 19; 
Tasp1–/–, n = 9; Gtf2a1nc/nc, 
n = 8. (C) Representative 
plots show reconstitution 
by donor hematopoietic 
stem cells (HSCs) of the 
indicated genotypes in B 
cell, T cell, and myeloid 
lineages assessed 12 
weeks after transplant. In 
each lineage, CD45.2+ and 
CD45.1+ cells were derived 
from donor (WT, Tasp1–/– or 
Gtf2a1nc/nc) and competitor 
cells, respectively. See also 
Table 1.
Table 1. Multilineage reconstitution from WT, Tasp1–/–, or Gtf2a1nc/nc donor HSCs
Donor HSC genotype Multilineage reconstitution
WT 13/19
Tasp1–/– 0/9A
Gtf2a1nc/nc 0/8B
The number of mice in which multilineage reconstitution was detected per group is shown. AP < 0.001, BP < 0.01 by the 
Fisher’s exact test (versus WT). HSCs, hematopoietic stem cells.
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controlled by developmentally essential genes. Taspase1 regulates the cell cycle, axial skeletal for-
mation, fetal HSC homeostasis, male germ cell development (11, 22, 36, 37), and craniofacial devel-
opment (23). As TFIIA complexes with not only TBP but also TRF2 (a male germ cell–enriched 
TBP variant) and TRF3 (a vertebrate-specific TBP variant), the Taspase1-TFIIA axis is positioned to 
orchestrate the assembly of  diverse tissue-specific or context-dependent transcription machinery that 
are crucial for organismal development.
Methods
Mice. Tasp1–/–, Mll1nc/nc, Mll2nc/nc, and Gtf2a1nc/nc mice have been previously described (11, 22). Tasp1+/– and 
Gtf2a1nc/+ mice were backcrossed to the WT C57BL6/J strain for 6 generations. Mll1nc/nc and Mll2nc/nc mice 
were similarly backcrossed to the WT C57BL6/J strain for 10 generations.
Flow cytometric analyses of  hematopoietic cells. To obtain single-cell suspensions of  hematopoietic cells, 
fetal livers were removed from E14.5 mouse embryos and homogenized by 3 passages through a 21-gauge 
needle. Freed cells were filtered through a nylon mesh with a pore size of  40 μm. Collected cells were 
treated with Red Blood Cell Lysing Buffer (MilliporeSigma) and then washed and filtered through nylon 
mesh. Automated blood cell counting was performed using a Hemavet Blood Analyzer (Drew Scientific). 
For mature blood cell analyses, 1 million cells were stained using the following antibodies: B220 APC 
(RA3-6B2) (BD Biosciences), Gr-1 PE (RB6-8C5) (BD Biosciences), and TER-119 Pacific Blue (TER-119) 
(BioLegend). For analyses of  stem and progenitor cells, 1 million cells were stained using a combination of  
following antibodies: Lin (lineage antibody cocktail from BioLegend: CD3 [17A2], CD4 [GK1.5], CD8α 
[53-6.7], B220 [RA3-6B2], TER-119 [TER-119], and Gr-1 [RB6-8C5]) Pacific Blue (BioLegend), Sca-1 PE 
(D7) (BD Biosciences), c-Kit APC/Alexa Fluor 750 (2B8) (BD Biosciences), CD34 FITC (RAM34) (BD 
Biosciences), CD16/32 Alexa Fluor 647 (clone 93) (eBioscience), and CD150 PE/Cy7 (TC15-12F12.2) 
(BioLegend). To identify and exclude dead cells, 7-AAD was added in the final suspension. Cells positive 
Figure 7. Homeotic transformation of axial skeletons in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc newborns. Lateral 
views of cervical (C1–C7) and upper thoracic (T1) regions demonstrate deformed anterior arch of atlas (C1) and fusion 
of C3–C4 (asterisks) in the Tasp1–/– and Gtf2a1nc/nc skeleton and posterior transformation of C7 with an additional rib 
(arrowheads) in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc skeleton (top row). Anterior views of the chest indicate incom-
plete ossification of sternebrae 4 (arrowheads) in Tasp1–/– and Gtf2a1nc/nc newborns and incomplete segmentation of 
sternebrae 3–4 (asterisks) in Mll1nc/nc;2nc/nc newborns (middle row). Anterior views of lower thoracic and lumbar vertebrae 
(L1–L6) demonstrate anterior transformation of L1 with an additional rib (arrowhead) in Tasp1–/– newborns and posterior 
transformation of L6 in Gtf2a1nc/nc newborns. See also Table 2.
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for Sca-1, CD34, or CD150 were determined by fluorescence-minus-one controls. Cells were analyzed with 
an LSRFortessa flow cytometer (BD Biosciences). Dot plots and histograms were made with FlowJo soft-
ware. Graphs and statistical analyses were prepared with GraphPad Prism 6.
Sorting of  hematopoietic stem and progenitor cells. Single-cell suspensions were prepared from fetal 
livers of  E14.5 embryos or adult bone marrow and stained as described above. Fetal liver cells from 
multiple littermate embryos of  the same genotype were pooled to ensure sufficient number of  cells for 
staining. Stained cells were subsequently double sorted using a FACSAria II (BD Biosciences) to a 
final purity of  more than 95%.
Competitive reconstitution assay. C57BL6/J-CD45.1 mice were used as recipients and competitors. 
The recipient mice were irradiated by 10 Gy divided into 2 fractions on the day –1. Competitor cells 
were prepared from E14.5 fetal livers from the C57BL6/J-CD45.1 mice and frozen in advance. On day 
0, LSK CD150+ HSCs were sorted from E14.5 fetal livers of  donor embryos that express CD45.2. Each 
recipient mouse was transplanted with 150 donor HSCs and 3 × 105 competitor fetal liver cells by tail 
vein injection. After 12 weeks, peripheral blood and bone marrow cells of  recipients were analyzed 
for the presence of  CD45.1+ and CD45.2+ cells by a LSRFortessa. Peripheral blood mononucleic cells 
were stained with the following antibodies for analyzing myeloid lineage: CD45.1 PE (A20) (BD Bio-
sciences), CD45.2 FITC (clone 104) (BD Biosciences), Mac-1 Ax647 (M1/70) (BD Biosciences), and 
Gr-1 Pacific Blue (RB6-8C5) (BioLegend). The following antibodies were used for lymphoid lineage: 
CD45.1 PE (A20), CD45.2 FITC (clone 104), B220 APC (RA3-6B2), and CD3 Pacific Blue (17A2).
Cell cycle analysis. Suspensions of  sorted hematopoietic stem and progenitor cells were fixed with eth-
anol overnight at 4°C, washed, and then resuspended in the house-made Nucleic Acid Staining Solution 
(38). Cells were stained with 7-AAD at room temperature for 20 minutes, followed by pyronin Y staining 
on ice for 15 minutes. Stained cells were analyzed by a LSRFortessa flow cytometer.
Annexin V assay. One million fetal liver cells were stained with the following antibodies: Lin Pacific 
Blue, Sca-1 PE (D7), c-Kit APC/Ax750 (2B8), and CD150 PE/Cy7 (TC15-12F12.2). The cells were sub-
sequently washed, stained with annexin V FITC (BioVision) and Propidium Iodide (MilliporeSigma), and 
then analyzed by flow cytometry.
Skeletal studies. P1 newborns were sacrificed and stained using Alizarin red (MilliporeSigma) and 
Alcian blue (MilliporeSigma) for bone and cartilage, respectively, as described previously (39).
Statistics. Statistical significance was evaluated using the Mann-Whitney U test for continuous variables, 
unless otherwise specified. χ2 testing was performed on cell cycle analyses, and P values of  independent 
experiments were combined by the Fisher’s method. P values of  less than 0.05 were considered significant.
Study approval. All animal work was performed in accordance to a protocol approved by the Institution-
al Animal Care and Use Committee of  Memorial Sloan Kettering Cancer Center.
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Table 2. Skeletal defects observed in Tasp1–/–, Gtf2a1nc/nc, and Mll1nc/nc;2nc/nc newborns
Skeletal defects WT (n = 14) Tasp1–/– (n = 17) Gtf2a1nc/nc (n = 17) MLL1nc/nc;2nc/nc (n = 10)
a.a.a., tilted, broadened, and deformed 14% (2) 47% (8) 82% (14) 20% (2)
C2, split neural arch 0% (0) 12% (2) 18% (3) 0% (0)
C3-5, fusion 0% (0) 76% (13) 29% (5) 0% (0)
C7, posterior transformation 0% (0) 94% (16) 65% (11) 50% (5)
T8, anterior transformation 0% (0) 59% (10) 12% (2) 0% (0)
Sternebrae 4, incomplete ossification 0% (0) 41% (7) 65% (11) 0% (0)
Sternebrae 3 and 4, incomplete segmentation 0% (0) 29% (5) 24% (4) 50% (5)
L1, anterior transformation 0% (0) 82% (14) 0% (0) 0% (0)
L6, posterior transformation 0% (0) 0% (0) 53% (9) 0% (0)
a.a.a., abnormal anterior arch of atlas.
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